EU Council’s Authorized Rep Liability Demands: Counter-Arguments, Alternatives, And Threat To TTIP
This article was originally published in Clinica
Fundamental legal anomalies are being identified that could shake the basis of proposals made by the Council of European Union to make authorized representatives fully liable for defective devices. These proposals, as they are, would mean that authorized representatives have to take up prohibitively expensive liability insurance in future to represent medical device and IVD manufacturers that do not have a base in the EU.
You may also be interested in...
The UK responsible person is the UK equivalent of the Authorized Representative in the EU. MedTech Europe’s Jesús Rueda gives an update on the early experiences of medtech manufacturers seeking to comply with the UK’s new standalone regulations.
The European Commission has reluctantly allowed virtual audits in the context of new MDR and IVDR. The EU notified body association is helping the collective effort to meet its strict requirements.
The new EU MDR rules for economic operators are complex and burdensome for those not used to them. Chad Reynolds of RMQ+ outlines practical strategies for managing economic operators efficiently, and with a view to long-term compliance.